Gastric reflux: the therapeutical role of Marial®
S.E. ARAGONA 1, G. MEREGHETTI 1 and G. CIPRANDI 2
1 Center of Regenerative Medicine – Humanitas Mater Domini, Castellanza (VA), Italy
2 Ospedale Policlinico San Martino, Genoa, Italy
The worldwide relevance of gastroesophageal reflux disease (GERD) has had a considerable increase in recent years. The guidelines for the diagnosis and treatment of GERD are well consolidated and continuously updated. Recently, the extra-esophageal manifestations of reflux have been considered from a multidisciplinary point of view, so the symptoms of the laryngo-pharyngeal reflux (LPR) have been precisely defined. At present, a new Medical Compound (Marial®) has the indication for the treatment of both GERD and LPR. Clinical experience has initially confirmed its effectiveness in both disorders.